Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Doxycycline for Bladder Pain in Men

Specific Indications for Doxycycline Use

  • The European Association of Urology recommends doxycycline (100 mg twice daily for 7 days) as a first-line treatment for non-gonococcal urethritis with associated bladder pain 1, 2
  • Doxycycline is particularly effective for urethritis caused by Chlamydia trachomatis, which can present with bladder pain and irritative voiding symptoms, as stated by the Centers for Disease Control and Prevention 3, 4
  • The European Urology guidelines recommend doxycycline (100 mg twice daily for 7 days) for Ureaplasma urealyticum infections that may cause bladder pain 2, 5

Diagnostic Criteria Before Initiating Treatment

  • The European Urology guidelines suggest performing validated nucleic acid amplification test (NAAT) on first-void urine or urethral smear to confirm chlamydial infection 1, 4
  • A Gram stain of urethral discharge should be performed to rule out gonococcal infection, as recommended by the European Urology guidelines 1
  • The Centers for Disease Control and Prevention recommend that treatment should ideally be delayed until NAAT results are available in patients with mild symptoms 1
  • Objective signs of urethritis should be present before initiating antimicrobial therapy, according to the Centers for Disease Control and Prevention 3, 6

Treatment Regimens

  • The primary regimen for doxycycline is 100 mg orally twice daily for 7 days, as recommended by the European Urology guidelines 1, 2
  • An alternative regimen is azithromycin 500 mg orally on day 1, then 250 mg daily for 4 days, as suggested by the European Urology guidelines and the Centers for Disease Control and Prevention 2, 4
  • For persistent non-gonococcal urethritis after initial doxycycline treatment, consider adding metronidazole 400 mg twice daily for 5 days, as recommended by the European Urology guidelines 2

Follow-Up Recommendations

  • Patients should return for evaluation if symptoms persist or recur after completing therapy, as recommended by the Centers for Disease Control and Prevention 3, 4
  • The Centers for Disease Control and Prevention recommend abstaining from sexual intercourse until 7 days after therapy initiation and symptoms have resolved 3, 4
  • Persistence of pain beyond 3 months should prompt evaluation for chronic prostatitis/chronic pelvic pain syndrome, according to the Centers for Disease Control and Prevention 3, 7
  • Consider testing for other STIs, including syphilis and HIV, in patients diagnosed with urethritis, as recommended by the Centers for Disease Control and Prevention 3

Important Caveats and Considerations

  • Doxycycline is not effective for gonococcal urethritis - ceftriaxone is the preferred treatment, as stated by the European Urology guidelines 1, 2
  • Sexual partners within the preceding 60 days should be referred for evaluation and treatment, according to the Centers for Disease Control and Prevention 3, 6
  • Symptoms alone without objective signs of urethritis are not sufficient basis for retreatment, as recommended by the Centers for Disease Control and Prevention 3, 4
  • In cases of recurrent urethritis after doxycycline treatment, consider tetracycline-resistant U. urealyticum, as suggested by the Centers for Disease Control and Prevention 3, 6
  • Approximately 50% of men with chronic pelvic pain syndrome have urethral inflammation without identifiable pathogens, according to the Centers for Disease Control and Prevention 3, 6

Special Populations

  • HIV-infected patients with non-gonococcal urethritis should receive the same treatment regimen as HIV-negative patients, as recommended by the Centers for Disease Control and Prevention 3, 7